Health Dictionary Find a Doctor

Drug induced liver injury differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rachita Navara, M.D. [2]

Overview

Overview

Drug induced liver injury must be differentiated from other diseases that cause serum transaminase elevations and symptoms of acute liver injury[1]:

Differential Diagnosis

Differential Diagnosis

The following diseases are in the differential of drug induced liver injury:

Some medications (e.g. minocycline, nitrofurantoin) cause autoimmune-like drug induced liver injury, which must be distinguished from autoimmune hepatitis using serum studies such as antinuclear antibody, immunoglobulin G, and anti-smooth muscle antibody.

In patients below the age of forty, it is important to rule out Wilson’s Disease, though rare, with serum ceruloplasmin. However, ceruloplasmin may also be falsely normal or even elevated as an acute-phase reactant during episodes of acute hepatitis. Further testing if indicated would include slit lamp examination and 24-hour urine copper collection.

If tender hepatomegaly and ascites are present, ultrasound with doppler should be obtained to assess for Budd-Chiari syndrome.

Other etiologies that may have overlapping presentations with cholestatic liver injury include:

References

References

  1. Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ; et al. (2014). “ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury”. Am J Gastroenterol. 109 (7): 950–66, quiz 967. doi:10.1038/ajg.2014.131. PMID 24935270.

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH